Frank has been chief of the Department of Laboratory Medicine at the National Institutes of Health Clinical Center since 2018.

Twelve Jacobs School of Medicine and Biomedical Sciences faculty members have received funding through the Undergraduate Research and Creative Activities Program for projects starting in January 2026.

Paramagnetic rim lesions and other imaging biomarkers that show up on MRI allow patients to be diagnosed and treated much sooner.

Complete the form below. It will be reviewed by GME leadership prior to being reviewed by the GMEC. Completed applications must be received at least 10 days prior to the next scheduled GMEC meeting, ...

BUFFALO, N.Y. — Artificial intelligence-enhanced wearable devices, such as continuous glucose monitors (CGMs), have dramatically improved the ability of people with diabetes and even prediabetes to ...

AI rapidly analyzes massive datasets — such as genomic data, clinical trial results, and electronic health records — to identify patterns and insights. Machine learning algorithms improve diagnostic ...

Siddiqui, who is chief executive officer and chief medical officer of the Jacobs Institute, performed indirect bypass, encephaloduroarteriosynagiosis (EDAS) surgery to restore adequate blood supply to ...

BUFFALO, N.Y. – Each year, more than 100,000 patients who have experienced a stroke or a transient ischemic attack (TIA), also known as a “mini-stroke,” undergo a carotid artery stenting procedure to ...

I am pleased to announce two important leadership transitions at the University at Buffalo’s Clinical and Translational Science Institute (CTSI) — a cornerstone of our efforts to transform scientific ...

A new children’s book, “Sofia Learns About Cancer Research,” explains how clinical trials work for children with cancer and their families. Written by a multidisciplinary team representing UB, Roswell ...

The first cancer patient Nick Salgia saw during his gap year working at an oncology research center had a rare and hyper-aggressive subtype of kidney cancer. Fortunately, a novel immunotherapy had ...